Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal …
10 个月之前
targetedonc.com
Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | OncLive
Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | …
1 周前
onclive.com
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripalimab in the Recurrent Setting | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripal…
11 个月之前
targetedonc.com
Targeting Recurrent and Metastatic NPC With Systemic Immunotherapy: The Role of Toripalimab and Insights From Radiation Oncology | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeting Recurrent and Metastatic NPC With Systemic Immunotherap…
1 周前
targetedonc.com
Proud to announce the launch of Toripalimab in India, the first and only immuno-oncology drug approved by various regulatory authorities around the world such as the USFDA, DCGI, EMA, MHRA and others for the treatment of adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab is a New Biological Entity (NBE). The combination of Toripalimab and standard of care chemotherapy has shown a 48% reduction in risk of progression or death, meeting a significant unmet need for p
0:18
Proud to announce the launch of Toripalimab in India, the first and …
已浏览 194 次2024年11月28日
FacebookDr. Reddy's Laboratories Ltd.
GFH018 and toripalimab combination therapy for previously treated recurrent or metastatic nasopharyngeal carcinoma: Results from a phase 1b/2 study - Watch Related Videos
6:15
GFH018 and toripalimab combination therapy for previousl…
2014年10月27日
jove.com
Phase II Trial Results of Disitamab Vedotin and Toripalimab Combination for Muscle-Invasive Bladder Cancer - Xinan Sheng
Phase II Trial Results of Disitamab Vedotin and Toripalimab Combina…
11 个月之前
urotoday.com
Junshi Biosciences Announces Toripalimab's NDA Accepted by th…
2024年2月2日
finanznachrichten.de
Dr. Rapisuwon on the Potential Utility of Toripalimab in Melanom…
2021年5月4日
onclive.com
Dr Yuan on 3-Year Data for Perioperative Toripalimab/Chemo …
1 个月前
onclive.com
Junshi Biosciences Announces Approval of sNDA for Toripalimab …
11 个月之前
thespec.com
4:56
Subcutaneous Toripalimab: Promising NSCLC Treatment | No…
2 个月之前
YouTubeThe Daily Wave
6:09
DIAMOND: toripalimab & radiotherapy in nasopharyngeal c…
已浏览 326 次8 个月之前
YouTubeVJOncology
5:28
What Is The Moa Of Loqtorzi Toripalimab
已浏览 73 次2024年7月18日
YouTubeRX Card Club
6:13
Toripalimab plus metronomic chemotherapy show efficacy in tre…
已浏览 276 次2024年2月20日
YouTubeecancer
1:26
Toripalimab #How is it different
已浏览 77 次4 个月之前
YouTubeCancer education made simple # Chandrakant…
Four-year outcomes with perioperative toripalimab plus che…
1 个月前
jove.com
2:22
NEOTORCH Trial: Perioperative Toripalimab for NSCLC - OncTalk …
已浏览 106 次2024年4月2日
YouTubeGlobal Resource for Advancing Cancer Education
Toripalimab FLOT Regimen Improves Gastric Cancer Outcome…
已浏览 2万 次1 个月前
linkedin.com
Coherus BioSciences obtient l'examen prioritaire de la FDA pou…
7 个月之前
zonebourse.com
3:23
Instagram
已浏览 3.8万 次6 个月之前
Instagramthecancerdoctor10
4:12
Chidamide plus toripalimab shows promise in advanced sarcoma
已浏览 70 次4 个月之前
YouTubeVJOncology
4:58
Toripalimab plus chemotherapy improves 3-year survival in resect…
1 个月前
Vimeoecancer
0:29
🚩 ICYMI! Nabil Saba, MD reminds that the JUPITER-02 trial's positive res…
已浏览 24 次2024年11月26日
FacebookMedscape Oncology
5:40
ASCO 2026 update l Is Toripalimab the GAME CHANGER for Resectab…
已浏览 549 次1 个月前
YouTubeEdusurg Clinics
1:33
RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in H…
已浏览 77 次4 个月之前
YouTubeVJOncology
China’s new cancer drug Toripalimab is approved in the US …
2023年11月29日
South China Morning PostVictoria Bela
8:24
RENOTORCH Phase III: Toripalimab + Axitinib vs Sunitinib in Advance…
已浏览 26 次6 个月之前
YouTubeCancer Research and Statistic Foundation
2:52
New cancer medicine Immunotherapy for Head & Neck, …
已浏览 5061 次2024年12月17日
YouTubeDr. Pratik Patil Oncologist
1:18:31
The Power and Promise of Immunotherapy in Head and Neck …
已浏览 4442 次2022年7月29日
YouTubePeerView Oncology
观看更多视频
静态缩略图占位符